Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses

Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses

Conventional T cells exhibit a delayed response to the initial priming of peptide antigens presented by major histocompatibility complex (MHC) proteins. Unlike conventional T cells, mucosal-associated invariant T (MAIT) cells quickly respond to non-peptidic metabolite antigens presented by MHC-relat...

Full description

Bibliographic Details
Main Authors:	Manju Sharma, Shuangmin Zhang, Liang Niu, David M. Lewinsohn, Xiang Zhang, Shouxiong Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Immunology
Subjects:	mucosal-associated invariant T (MAIT) cells transcriptome MHC-related protein 1 (MR1) Mycobacterium tuberculosis innate-like activation
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01136/full

Similar Items

Comparative transcriptomes reveal pro-survival and cytotoxic programs of mucosal-associated invariant T cells upon Bacillus Calmette–Guérin stimulation
by: Manju Sharma, et al.
Published: (2023-04-01)

The role of mucosal associated invariant T cells in antimicrobial immunity
by: Ruth J Napier, et al.
Published: (2015-07-01)

Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries
by: Alexandra J. Corbett, et al.
Published: (2020-08-01)

The role of mucosal-associated invariant T cells in visceral leishmaniasis
by: Marcela de Lima Moreira, et al.
Published: (2022-09-01)

Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation
by: Caroline L. Ashley, et al.
Published: (2023-02-01)

A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus
by: Goh Murayama, et al.
Published: (2019-11-01)

Mucosal-Associated Invariant T Cells in the Digestive System: Defender or Destroyer?Summary
by: Hejiao Zhang, et al.
Published: (2023-01-01)

Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions
by: Emmanuel Treiner, et al.
Published: (2023-03-01)

Mucosal-associated invariant T cells repress group 2 innate lymphoid cells in Alternaria alternata-induced model of allergic airway inflammation
by: Yasuo Shimizu, et al.
Published: (2022-11-01)

Role of CD1d- and MR1-Restricted T Cells in Asthma
by: Chiaki Iwamura, et al.
Published: (2018-08-01)

Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
by: Ruchi Jain Dey, et al.
Published: (2022-02-01)

Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization
by: Yanmei Li, et al.
Published: (2018-09-01)

Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients
by: Sebastian Deschler, et al.
Published: (2021-02-01)

Mucosal-associated invariant T (MAIT) cells: new players in anti-bacterial immunity
by: James E Ussher, et al.
Published: (2014-10-01)

MicroRNA-155 Regulates MAIT1 and MAIT17 Cell Differentiation
by: Tingting Liu, et al.
Published: (2021-04-01)

Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis
by: Yoseph Asmelash Gebru, et al.
Published: (2021-02-01)

Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series
by: Pietro Torre, et al.
Published: (2022-06-01)

It Takes “Guts” to Cause Joint Inflammation: Role of Innate-Like T Cells
by: Céline Mortier, et al.
Published: (2018-06-01)

Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis
by: Shubhanshi Trivedi, et al.
Published: (2020-11-01)

Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments
by: Corinna Kulicke, et al.
Published: (2020-09-01)

Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy
by: Ellie-May Jarvis, et al.
Published: (2021-10-01)

Die Kämpfe únd schláchten—the struggles and battles of innate-like effector T lymphocytes with microbes
by: Sebastian Joyce, et al.
Published: (2023-04-01)

Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
by: Melanie eHarriff, et al.
Published: (2012-03-01)

Lipid specific and vitamin specific non-MHC restricted T cells: new players in human pathophysiology.
by: Mariolina eSalio, et al.
Published: (2015-07-01)

Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans
by: Gwendolyn M. Swarbrick, et al.
Published: (2020-09-01)

Current Perspectives and Challenges of MAIT Cell-Directed Therapy for Tuberculosis Infection
by: Melissa D. Chengalroyen
Published: (2023-11-01)

Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child
by: Liana Ghazarian, et al.
Published: (2017-12-01)

Mucosal-associated invariant T cells in infectious diseases of respiratory system: recent advancements and applications
by: Xue Lin, et al.
Published: (2024-02-01)

MAIT Cells Balance the Requirements for Immune Tolerance and Anti-Microbial Defense During Pregnancy
by: Johanna Raffetseder, et al.
Published: (2021-08-01)

Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma
by: Ayako Ishimori, et al.
Published: (2017-04-01)

Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
by: Mariann Szabó, et al.
Published: (2017-11-01)

Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells
by: Nicholas M. Provine, et al.
Published: (2018-04-01)

Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
by: Yusuke Yasutomi, et al.
Published: (2022-01-01)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
by: Yan-Ruide Li, et al.
Published: (2022-06-01)

Varicella Zoster Virus infects mucosal associated Invariant T cells
by: Shivam K. Purohit, et al.
Published: (2023-03-01)

Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet–Fed Mice
by: Haruka Kishi, et al.
Published: (2022-12-01)

Understanding the Role of Mucosal-Associated Invariant T-Cells in Non-human Primate Models of HIV Infection
by: Isaac M. Barber-Axthelm, et al.
Published: (2020-08-01)

Target tumor microenvironment by innate T cells
by: Yan-Ruide Li, et al.
Published: (2022-10-01)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
by: Lucy C. Garner, et al.
Published: (2018-06-01)

Role of innate T cells in necrotizing enterocolitis
by: Jianyun Liu, et al.
Published: (2024-02-01)